These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28095294)

  • 21. Rare Cause of Infantile Hypercalcemia: A Novel Mutation in the SLC34A1 Gene.
    Kurnaz E; Savaş Erdeve Ş; Çetinkaya S; Aycan Z
    Horm Res Paediatr; 2019; 91(4):278-284. PubMed ID: 30227399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bartter Syndrome Type 1 Due to Novel
    Kiuchi Z; Nozu K; Yan K; Jüppner H
    JCEM Case Rep; 2023 Mar; 1(2):luad019. PubMed ID: 37908481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic heterogeneity in patients with Bartter syndrome type 1.
    Sun M; Ning J; Xu W; Zhang H; Zhao K; Li W; Li G; Li S
    Mol Med Rep; 2017 Feb; 15(2):581-590. PubMed ID: 28000888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
    Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
    Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3.
    García-Castaño A; Gómez-Conde S; Gondra L; Herrero M; Aguirre M; de la Hoz AB; Castaño L; ; Madariaga L
    Sci Rep; 2023 Aug; 13(1):12587. PubMed ID: 37537162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial hypercalcemia and hypercalciuria: no mutations in the Ca2+-sensing receptor gene.
    Rodríguez-Soriano J; Vallo A; Quintela MJ; Pérez de Nanclares G; Bilbao JR; Castaño L
    Pediatr Nephrol; 2001 Sep; 16(9):748-51. PubMed ID: 11511994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet.
    García Soblechero E; Ferrer Castillo MT; Jiménez Crespo B; Domínguez Quintero ML; González Fuentes C
    Neonatology; 2013; 104(2):104-8. PubMed ID: 23817301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic Infantile Hypercalcemia, Presenting in Adulthood--No Longer Idiopathic Nor Infantile: Two Case Reports and Review.
    Tray KA; Laut J; Saidi A
    Conn Med; 2015; 79(10):593-7. PubMed ID: 26731879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary kidney tubular diseases].
    Sasaki S
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():107-11. PubMed ID: 17899836
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of Bartter syndrome type I with atypical presentations.
    Lee EH; Heo JS; Lee HK; Han KH; Kang HG; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2010 Aug; 53(8):809-13. PubMed ID: 21189980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel MAGED2 variant in a Chinese preterm newborn with transient antenatal Bartter's syndrome with 4 years follow-up.
    Ma M; Zhang M; Zhou Y; Yao F; Wei M; Li Z; Qiu Z
    BMC Nephrol; 2021 Dec; 22(1):408. PubMed ID: 34895150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bartter's syndrome: clinical findings, genetic causes and therapeutic approach.
    Mrad FCC; Soares SBM; de Menezes Silva LAW; Dos Anjos Menezes PV; Simões-E-Silva AC
    World J Pediatr; 2021 Feb; 17(1):31-39. PubMed ID: 32488762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.
    Jobst-Schwan T; Pannes A; Schlingmann KP; Eckardt KU; Beck BB; Wiesener MS
    Kidney Blood Press Res; 2015; 40(5):443-51. PubMed ID: 26304832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.
    Ferraro PM; Minucci A; Primiano A; De Paolis E; Gervasoni J; Persichilli S; Naticchia A; Capoluongo E; Gambaro G
    Urolithiasis; 2017 Jun; 45(3):291-294. PubMed ID: 27639704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
    Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
    J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.